Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4324

2.

Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.

Godsland IF, Crook D, Devenport M, Wynn V.

Contraception. 1995 Sep;52(3):143-9.

PMID:
7587185
3.

Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.

Sheu WH, Hsu CH, Chen YS, Jeng CY, Fuh MM.

Clin Endocrinol (Oxf). 1994 Feb;40(2):249-55.

PMID:
8137525
4.

The effects of dietary lipid modification on blood pressure, cardiovascular reactivity and sympathetic activity in man.

Straznicky NE, Louis WJ, McGrade P, Howes LG.

J Hypertens. 1993 Apr;11(4):427-37.

PMID:
8390511
5.

A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.

Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.

Am J Obstet Gynecol. 1993 Nov;169(5):1183-9.

PMID:
8238183
6.

Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.

Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB.

Contraception. 1987 Mar;35(3):229-43.

PMID:
2956055
7.

The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.

N Engl J Med. 1990 Nov 15;323(20):1375-81.

9.

[Influence of progestins on adverse effects of oral contraceptives].

Wynn V.

Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):425-30. French.

PMID:
12280210
10.

Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.

Greenlund KJ, Webber LS, Srinivasan S, Wattigney W, Johnson C, Berenson GS.

Ann Epidemiol. 1997 Nov;7(8):561-7.

PMID:
9408552
12.
13.
14.

Effects of oral contraceptives on free fatty acid metabolism in women.

Jensen MD, Levine J.

Metabolism. 1998 Mar;47(3):280-4.

PMID:
9500563
15.

Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.

Spellacy WN, Birk SA, Buggie J, Buhi WC.

J Reprod Med. 1981 Jun;26(6):295-8.

PMID:
7019435
16.

[Metabolic risks of oral contraception].

Monier L.

Rev Int Pediatr. 1988 Feb;(178):64-5. French.

PMID:
12282576
17.

Long-term effects of the combined oral contraceptive pill on carbohydrate and lipid metabolism in Singapore women--a cross-sectional study.

Ng CS, Chng JW, Oakley NW, Wynn V, Ratnam SS.

Ann Acad Med Singapore. 1982 Oct;11(4):567-74.

PMID:
6762138
18.

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A.

Am J Obstet Gynecol. 2008 Nov;199(5):529.e1-529.e10. doi: 10.1016/j.ajog.2008.04.013. Epub 2008 Jun 4.

PMID:
18533124

Supplemental Content

Support Center